QIAGEN NV (QGEN)
40.89
-0.12
(-0.29%)
USD |
NYSE |
Apr 10, 15:43
QIAGEN Price : 40.89 for April 10, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| InflaRx NV | 0.9966 |
| CDT Equity, Inc. | 3.72 |
| LENZ Therapeutics, Inc. | 9.04 |
| Liminatus Pharma, Inc. | 0.1859 |
| Oruka Therapeutics, Inc. | 59.50 |
Price Related Metrics
| PE Ratio | 19.88 |
| PS Ratio | 4.043 |
| PEG Ratio | 0.0475 |
| Price to Book Value | 2.215 |
| Price to Free Cash Flow | 18.89 |
| Earnings Yield | 5.03% |
| Market Cap | 8.423B |
| PEGY Ratio | 0.0475 |
| Operating PE Ratio | 16.20 |
| Normalized PE Ratio | 18.26 |